134 related articles for article (PubMed ID: 8640912)
1. Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats.
Sargent LM; Dragan YP; Sattler C; Bahnub N; Sattler G; Martin P; Cisneros A; Mann J; Thorgeirsson S; Jordan VC; Pitot HC
Carcinogenesis; 1996 May; 17(5):1051-6. PubMed ID: 8640912
[TBL] [Abstract][Full Text] [Related]
2. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells).
Styles JA; Davies A; Davies R; White IN; Smith LL
Carcinogenesis; 1997 Feb; 18(2):303-13. PubMed ID: 9054622
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic administration of mestranol, tamoxifen, and toremifene on hepatic ploidy in rats.
Dragan YP; Shimel RJ; Bahnub N; Sattler G; Vaughan JR; Jordan VC; Pitot HC
Toxicol Sci; 1998 Jun; 43(2):129-38. PubMed ID: 9710954
[TBL] [Abstract][Full Text] [Related]
4. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley rats.
Sargent LM; Dragan YP; Bahnub N; Wiley JE; Sattler CA; Schroeder P; Sattler GL; Jordan VC; Pitot HC
Cancer Res; 1994 Jul; 54(13):3357-60. PubMed ID: 8012949
[TBL] [Abstract][Full Text] [Related]
6. Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver.
Williams GM; Iatropoulos MJ; Karlsson S
Carcinogenesis; 1997 Nov; 18(11):2247-53. PubMed ID: 9395228
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens.
Hirsimäki P; Hirsimäki Y; Nieminen L; Payne BJ
Arch Toxicol; 1993; 67(1):49-54. PubMed ID: 8452480
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of antiestrogens.
Hirsimäki P; Aaltonen A; Mäntylä E
Breast J; 2002; 8(2):92-6. PubMed ID: 11896754
[TBL] [Abstract][Full Text] [Related]
9. Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in the rat.
Ahotupa M; Hirsimäki P; Pärssinen R; Mäntylä E
Carcinogenesis; 1994 May; 15(5):863-8. PubMed ID: 8200088
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis.
Kärki A; Mäntylä E; Hirsimäki Y; Karlsson S; Toikkanen S; Hirsimäki P
Arch Toxicol; 2000 Jul; 74(4-5):249-56. PubMed ID: 10959800
[TBL] [Abstract][Full Text] [Related]
11. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.
Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM
Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624
[TBL] [Abstract][Full Text] [Related]
12. Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver.
Montandon F; Williams GM
Arch Toxicol; 1994; 68(4):272-5. PubMed ID: 8067901
[TBL] [Abstract][Full Text] [Related]
13. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.
Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM
Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and toremifene o-quinones.
Yao D; Zhang F; Yu L; Yang Y; van Breemen RB; Bolton JL
Chem Res Toxicol; 2001 Dec; 14(12):1643-53. PubMed ID: 11743747
[TBL] [Abstract][Full Text] [Related]
15. 17beta-estradiol, diethylstilbestrol, tamoxifen, toremifene and ICI 164,384 induce morphological transformation and aneuploidy in cultured Syrian hamster embryo cells.
Tsutsui T; Taguchi S; Tanaka Y; Barrett JC
Int J Cancer; 1997 Jan; 70(2):188-93. PubMed ID: 9009159
[TBL] [Abstract][Full Text] [Related]
16. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro.
Hemminki K; Widlak P; Hou SM
Carcinogenesis; 1995 Jul; 16(7):1661-4. PubMed ID: 7614704
[TBL] [Abstract][Full Text] [Related]
17. The proliferation in uterine compartments of intact rats of two different strains exposed to high doses of tamoxifen or toremifene.
Karlsson S; Iatropoulos MJ; Williams GM; Kangas L; Nieminen L
Toxicol Pathol; 1998; 26(6):759-68. PubMed ID: 9864093
[TBL] [Abstract][Full Text] [Related]
18. Alternate antiestrogens and approaches to the prevention of breast cancer.
Jordan VC
J Cell Biochem Suppl; 1995; 22():51-7. PubMed ID: 8538210
[TBL] [Abstract][Full Text] [Related]
19. Genotoxicity studies with the antiestrogen toremifene.
Williams GM; Ross PM; Jeffrey AM; Karlsson S
Drug Chem Toxicol; 1998 Nov; 21(4):449-76. PubMed ID: 9839155
[TBL] [Abstract][Full Text] [Related]
20. Idoxifene derivatives are less reactive to DNA than tamoxifen derivatives, both chemically and in human and rat liver cells.
Osborne MR; Hewer A; Davis W; Strain AJ; Keogh A; Hardcastle IR; Phillips DH
Carcinogenesis; 1999 Feb; 20(2):293-7. PubMed ID: 10069467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
